Alerts will be sent to your verified email
Verify Email
AMRUTANJAN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Amrutanjan Health Care Ltd manufactures a variety of ayurvedic and allopathic products available in several countries worldwide. The company also plans to expand into the US and European markets with a diverse product portfolio including pain relief products, ointments, and supplements.
Amrutanjan Healthcar major competitors are Max India, Sastasundar Ventures, Rajnish Wellness, Cupid, Jeena Sikho Life, Medplus Health Servi, Dr Agarwals Eye Hsp.
Market Cap of Amrutanjan Healthcar is ₹2,217 Crs.
While the median market cap of its peers are ₹2,187 Crs.
Amrutanjan Healthcar seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun | |||||||||||||||||
| Investor Presentation | May Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | |||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
